Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Promising Antivirals Against Chikungunya Virus
Friederike I. L. Hucke, Joachim J. Bugert
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development
Thaíse Yasmine Vasconcelos de Lima Cavalcanti, Mylena Ribeiro Pereira, Sérgio Oliveira de Paula, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 969-969
Open Access | Times Cited: 152
Chikungunya: An Emerging Public Health Concern
Omar Mourad, Leila Makhani, Lin H. Chen
Current Infectious Disease Reports (2022) Vol. 24, Iss. 12, pp. 217-228
Open Access | Times Cited: 46
Chikungunya: risks for travellers
Fabrice Simon, Éric Caumes, Tomáš Jelı́nek, et al.
Journal of Travel Medicine (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 35
Development of Automated Image Processing for High-Throughput Screening of Potential Anti-Chikungunya Virus Compounds
Pathaphon Wiriwithya, Siwaporn Boonyasuppayakorn, Pattadon Sawetpiyakul, et al.
Applied Sciences (2025) Vol. 15, Iss. 1, pp. 385-385
Open Access | Times Cited: 1
The research progress of Chikungunya fever
Li Cai, Xinyi Hu, Shuang Liu, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 17
Pathogenicity and virulence of chikungunya virus
Wesley Freppel, Laurie A. Silva, Kenneth A. Stapleford, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Chikungunya: The Silent Threat in the Shadows
Ambreen Talib, Rabbya Rayan Shah, Rameen Atique, et al.
Clinical Microbiology Newsletter (2025)
Closed Access
Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti‐Alphavirus Therapies
Sainan Wang, Suresh Mahalingam, Andres Merits
Reviews in Medical Virology (2025) Vol. 35, Iss. 2
Open Access
Exploration of potential inhibitors against chikungunya envelope: an in-silico clue
Aparna Chaudhuri, Bidyut Bandyopadhyay, Buddhadev Mondal, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures
Alyssa M. Lantz, Victoria K. Baxter
Viruses (2025) Vol. 17, Iss. 2, pp. 261-261
Open Access
Revolutionizing Chikungunya Vaccines: mRNA Breakthroughs With Molecular and Immune Simulations
Md. Habib Ullah Masum, Ahmad Abdullah Mahdeen, Abanti Barua
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Chikungunya virus and other emerging arthritogenic alphaviruses
William Marciel de Souza, Marc Lecuit, Scott C. Weaver
Nature Reviews Microbiology (2025)
Closed Access
Mode-Dependent Antiviral Activity of Medicinal Plant Extracts against the Mosquito-Borne Chikungunya Virus
Sze Mun Chan, Kong Soo Khoo, Shamala Devi Sekaran, et al.
Plants (2021) Vol. 10, Iss. 8, pp. 1658-1658
Open Access | Times Cited: 18
Inhibitors of the Structural and Nonstructural Proteins of Alphaviruses
Damilohun Samuel Metibemu, Olawale Samuel Adeyinka, John Adeolu Falode, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 2507-2524
Closed Access | Times Cited: 2
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening
Jasmin C. Aschenbrenner, André S. Godoy, M. Fairhead, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251
Friederike I. L. Hucke, Malena Bestehorn, Marcella Bassetto, et al.
Virus Genes (2022) Vol. 58, Iss. 3, pp. 188-202
Open Access | Times Cited: 10
The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus
Ana C. Puhl, R.S. Fernandes, André S. Godoy, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 83, pp. 117239-117239
Open Access | Times Cited: 6
Chikungunya and Zika Viruses: Co-Circulation and the Interplay between Viral Proteins and Host Factors
Sineewanlaya Wichit, Nuttamonpat Gumpangseth, Rodolphe Hamel, et al.
Pathogens (2021) Vol. 10, Iss. 4, pp. 448-448
Open Access | Times Cited: 13
The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication
Lucca Rocha Policastro, Isabela Dolci, André S. Godoy, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1351-1351
Open Access | Times Cited: 9
Inhibition of Chikungunya Virus Infection by 4-Hydroxy-1-Methyl-3-(3-morpholinopropanoyl)quinoline-2(1H)-one (QVIR) Targeting nsP2 and E2 Proteins
Mohammad Islamuddin, Obaid Afzal, Wajihul Hasan Khan, et al.
ACS Omega (2021) Vol. 6, Iss. 14, pp. 9791-9803
Open Access | Times Cited: 11
MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro , In Vivo , and Ex Vivo
Saikat De, Soumyajit Ghosh, Supriya Suman Keshry, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 7
Open Access | Times Cited: 8
Development and Application of Treatment for Chikungunya Fever
Erin M. Millsapps, Emma C. Underwood, Kelli L. Barr
Research and Reports in Tropical Medicine (2022) Vol. Volume 13, pp. 55-66
Open Access | Times Cited: 8
High-Throughput Molecular Modeling and Evaluation of the Anti-Inflammatory Potential of Açaí Constituents against NLRP3 Inflammasome
Elaine Cristina Medeiros da Rocha, João Augusto Pereira da Rocha, Renato Araújo da Costa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8112-8112
Open Access | Times Cited: 1
Demystifying therapeutic potential of medicinal plants against chikungunya virus
Sukender Kumar, Chanchal Garg, Samander Kaushik, et al.
Indian Journal of Pharmacology (2021) Vol. 53, Iss. 5, pp. 403-403
Closed Access | Times Cited: 10
In silico studies revealed interaction mechanisms of benzylidene–acrylohydrazide derivatives and nsP2 CHIKV
L. MUNIZ, Samuel Silva da Rocha Pita
New Journal of Chemistry (2022) Vol. 46, Iss. 14, pp. 6414-6423
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top